HLS Therapeutics Inc.

TSX:HLS Lagerbericht

Marktkapitalisierung: CA$114.5m

HLS Therapeutics Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

HLS Therapeutics wird ein Gewinn- und Umsatzwachstum von 6% bzw. 2% pro Jahr prognostiziert, während der Gewinn pro Aktie um 7.6% pro Jahr wachsen soll.

Wichtige Informationen

10.3%

Wachstumsrate der Gewinne

12.3%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum50.4%
Wachstumsrate der Einnahmen3.7%
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

Low

Zuletzt aktualisiert09 Aug 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Analysts Have Lowered Expectations For HLS Therapeutics Inc. (TSE:HLS) After Its Latest Results

May 12
Analysts Have Lowered Expectations For HLS Therapeutics Inc. (TSE:HLS) After Its Latest Results

Recent updates

Analysts Have Lowered Expectations For HLS Therapeutics Inc. (TSE:HLS) After Its Latest Results

May 12
Analysts Have Lowered Expectations For HLS Therapeutics Inc. (TSE:HLS) After Its Latest Results

After Leaping 29% HLS Therapeutics Inc. (TSE:HLS) Shares Are Not Flying Under The Radar

Apr 14
After Leaping 29% HLS Therapeutics Inc. (TSE:HLS) Shares Are Not Flying Under The Radar

Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt

Apr 06
Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt

Analysts Are More Bearish On HLS Therapeutics Inc. (TSE:HLS) Than They Used To Be

Nov 16
Analysts Are More Bearish On HLS Therapeutics Inc. (TSE:HLS) Than They Used To Be

Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt

Sep 13
Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt

Would HLS Therapeutics (TSE:HLS) Be Better Off With Less Debt?

May 05
Would HLS Therapeutics (TSE:HLS) Be Better Off With Less Debt?

HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

Apr 05
HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Is Paying Out A Dividend Of $0.05

Mar 20
HLS Therapeutics (TSE:HLS) Is Paying Out A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of $0.05

Nov 30
HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of $0.05

Downgrade: Here's How Analysts See HLS Therapeutics Inc. (TSE:HLS) Performing In The Near Term

Nov 11
Downgrade: Here's How Analysts See HLS Therapeutics Inc. (TSE:HLS) Performing In The Near Term

We Think HLS Therapeutics (TSE:HLS) Has A Fair Chunk Of Debt

Sep 14
We Think HLS Therapeutics (TSE:HLS) Has A Fair Chunk Of Debt

HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

Aug 15
HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

Jul 14
HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Has Announced A Dividend Of CA$0.05

Jun 23
HLS Therapeutics (TSE:HLS) Has Announced A Dividend Of CA$0.05

HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

Jun 08
HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

May 25
HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

May 10
HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

Time To Worry? Analysts Are Downgrading Their HLS Therapeutics Inc. (TSE:HLS) Outlook

Apr 30
Time To Worry? Analysts Are Downgrading Their HLS Therapeutics Inc. (TSE:HLS) Outlook

HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of CA$0.05

Apr 15
HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of CA$0.05

HLS Therapeutics (TSE:HLS) Has Re-Affirmed Its Dividend Of CA$0.05

Mar 26
HLS Therapeutics (TSE:HLS) Has Re-Affirmed Its Dividend Of CA$0.05

HLS Therapeutics Inc. (TSE:HLS) Analysts Just Slashed This Year's Estimates

Mar 22
HLS Therapeutics Inc. (TSE:HLS) Analysts Just Slashed This Year's Estimates

HLS Therapeutics (TSE:HLS) Will Pay A Dividend Of CA$0.05

Nov 29
HLS Therapeutics (TSE:HLS) Will Pay A Dividend Of CA$0.05

Gewinn- und Umsatzwachstumsprognosen

TSX:HLS - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/202672-14N/AN/A1
12/31/202565-12N/AN/A4
12/31/202458-19775
6/30/202459-241212N/A
3/31/202461-281213N/A
12/31/202363-281616N/A
9/30/202363-291516N/A
6/30/202363-26414N/A
3/31/202362-26515N/A
12/31/202261-24717N/A
9/30/202261-21717N/A
6/30/202261-191617N/A
3/31/202260-121215N/A
12/31/202160-131216N/A
9/30/202161-161118N/A
6/30/202159-16-2217N/A
3/31/202157-20-2811N/A
12/31/202056-15-359N/A
9/30/202054-20-416N/A
6/30/202054-21-910N/A
3/31/202055-16423N/A
12/31/201954-201126N/A
9/30/201957-71135N/A
6/30/201959-252235N/A
3/31/201961-241428N/A
12/31/201861-251833N/A
9/30/201865-262830N/A
6/30/201870-82033N/A
3/31/201873-8N/A37N/A
12/31/201775-6N/A27N/A
9/30/201771-11N/A25N/A
12/31/201654-15N/A22N/A
12/31/201520-10N/A-6N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: HLS wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: HLS wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: HLS wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: HLSDie Einnahmen des Unternehmens (2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Canadian (7.3% pro Jahr).

Hohe Wachstumseinnahmen: HLSDie Einnahmen des Unternehmens (2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von HLS in 3 Jahren voraussichtlich hoch sein wird

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y